Résumé Objectif La milrinone inhalée est utilisée pour traiter l'hypertension pulmonaire (HP)
mais son efficacité, son innocuité et ses effets prophylactiques pour faciliter le sevrage de la …

Pulmonary hypertensive crisis is an important cause of morbidity and mortality in patients
with pulmonary arterial hypertension secondary to congenital heart disease (PAH-CHD) …

Despite great advances in the understanding of the genetics and pathophysiology of cystic
fibrosis (CF), there is still no cure for the disease. Using phosphodiesterase type 5 (PDE5) …

Die erneute Aktualisierung der Leitlinie beinhaltete wiederum eine erneute systematische
Literaturrecherche nach den gleichen Vorgaben, die den Zeitraum von November 2009 bis …

Objective To report the authors' 12 years of experience with intratracheal milrinone
administration and to assess the efficacy and limitations of intratracheal milrinone bolus …

Neurodegenerative disease appears as a result of genomic lesions which lead to alterations
at multiple levels like genomic product and biological pathways. It involves destruction of …

Die erneute Aktualisierung der Leitlinie beinhaltete wiederum eine erneute systematische
Literaturrecherche nach den gleichen Vorgaben, die den Zeitraum von November 2009 bis …

Recent basic research has aroused great interest in the therapeutic potential of
phosphodiesterase type 5 (PDE5) inhibitors, such as sildenafil, vardenafil and taladafil, for …

Purpose Inhaled milrinone (iMil) has been used for the treatment of pulmonary hypertension
(PH) but its efficacy, safety, and prophylactic effects in facilitating separation from …

Conclusion In high-risk cardiac surgery patients with PH, the prophylactic use of iMil was
associated with favourable hemodynamic effects that did not translate into improvement of …